EPL Activities at the 34th American College of Toxicology (ACT) Annual Meeting
EPL is pleased to announce that we will be exhibiting once again at the American College of Toxicology (ACT) Annual Meeting in San Antonio, TX. Come visit us at Booth #310!!
At this meeting, EPL is co-sponsoring a CE Course along with RTI International entitled, “Screening and Testing for Reproductive and Developmental Toxicity,” to be held Sunday, November 3, 2013 from 8:00am – 11:30am. Dr. Jerry Hardisty will serve as a Chairperson. The course will detail a new optimized study design, the Modified One-Generation (MOG) study, developmental windows and vulnerabilities for the rodent and human reproductive system, immune system, and nervous system, and the toxicities associated with the development of these systems.
EPL is also co-sponsoring a CE Course along with Covance, Inc. entitled, “All Eyes Focused on Ocular Toxicology and Pathology,” to be held Sunday, November 3, 2013 from 1:00pm – 4:30pm. Dr. Margarita Gruebbel will serve as a Chairperson. This session will provide detailed reviews of the anterior and posterior ocular segments of common laboratory animal species with regard to comparative anatomy and physiology, common methods used to determine treatment-related effects in ocular structures, as well as a description of spontaneous and induced changes observed in each segment of the eye.
Additionally, Dr. Tom Steinbach will serve as a Chairperson for the CE Course, “Relevance of Animal Tumors in Assessing Human Risk of Pharmaceuticals.” This session will take place on Sunday, November 3, 2013 from 8:00am – 11:30am and will present an overview of animal tumors that may not be relevant for human risk assessment. In addition, speakers will discuss various approaches for determining relevance of animal tumors and present specific examples where additional mechanistic data impacted the risk assessment and the approval process. The symposium will also present how regulatory agencies approach the relevance of animal tumor data to assess human risk of carcinogenicity.
Dr. Kathleen Funk will be serving as a Chairperson for the Symposium, “Clinical, Regulatory, and Nonclinical Study Design Issues Associated with Testing and Approval of Medical Devices.” This session will be held on Monday, November 4, 2013 from 2:00pm – 5:00pm.
For more information, please visit www.actox.org.